• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 23, 2018

View Archived Issues

Nailin approved in Japan for onychomycosis

Read More

AnGes submits application for marketing approval of HGF gene therapy in Japan

Read More

EC extends approval of Adcetris to include cutaneous T-cell lymphoma

Read More

Eureka Therapeutics closes series D financing round to advance lead candidate

Read More

Charcoal-delivering DAV-132 protects gut microbiome from antibiotic residues

Read More

BMS's Yervoy approved in E.U. for melanoma in pediatric patients

Read More

EMA committee gives positive opinion on orphan drug status for OMS-721

Read More

Phase III studies of reslizumab in eosinophilic asthma miss primary endpoints

Read More

Novartis completes tender offer for Advanced Accelerator Applications

Read More

BioCryst Pharmaceuticals and Idera Pharmaceuticals enter merger agreement

Read More

Imara initiates proof-of-concept phase II study of IMR-687 in sickle cell anemia

Read More

Board recommends continuation of Cynata Therapeutics' phase I study of CYP-001

Read More

New data suggest potential of once- or twice-weekly dosing of glepaglutide for short bowel syndrome

Read More

FDA grants fast track designation to SOBI-003 and accepts IND for first-in-human study

Read More

Genfit launches pediatric NASH program with elafibranor

Read More

Sucrose non-fermenting related kinase identified as a target for treating obesity

Read More

Phase IIIb trial of Aimovig meets endpoints in treatment-failure patients with episodic migraine

Read More

Venenum Biodesign discovers G-protein coupled bile acid receptor 1 agonists

Read More

Myeloperoxidase/eosinophil peroxidase inhibitors patented by Bristol-Myers Squibb

Read More

Jeil Pharmaceutical synthesizes novel H(+)/K(+) ATPase inhibitors

Read More

New lysyl-tRNA synthetase/laminin receptor interaction inhibitors patented by Yuhan

Read More

Regeneron synthesizes novel anti-GITR antibodies

Read More

Medeor Therapeutics awarded funding for phase III study of MDR-101

Read More

Pulmatrix cleared to begin first-in-human study of Pulmazole in U.K.

Read More

Celgene to acquire Juno Therapeutics

Read More

AP-202 shows promise as an agent for nicotine addiction

Read More

Nymox reports 5-year results from fexapotide triflutate study

Read More

Agenus launches AGEN-1884/AGEN-2034 combination study

Read More

Athenex reports results from two clinical studies of Oraxol

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe